{"pmid":32492197,"title":"SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences.","text":["SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences.","Nowadays, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused novel coronavirus disease (COVID-19) pandemic, is the worldwide challenge. The virus is highly contagious, and clinical consequences were very divers. It is estimated that if no effective action is taken, COVID-19 could plague 90% of the world's population and kill over 40 million people. So, it is essential to understand the virus pathogenicity and follow the preventive methods to control the high morbidity and mortality rates. Meanwhile our current knowledge of COVID-19 is still limited, despite hard efforts of scientists and clinicians during last few months. In this review article, we have collected the latest data about characteristics, pathogenesis, clinical manifestations, and diagnostic methods of SARS-CoV-2. This article is protected by copyright. All rights reserved.","J Med Virol","Lotfi, Melika","Rezaei, Nima","32492197"],"abstract":["Nowadays, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused novel coronavirus disease (COVID-19) pandemic, is the worldwide challenge. The virus is highly contagious, and clinical consequences were very divers. It is estimated that if no effective action is taken, COVID-19 could plague 90% of the world's population and kill over 40 million people. So, it is essential to understand the virus pathogenicity and follow the preventive methods to control the high morbidity and mortality rates. Meanwhile our current knowledge of COVID-19 is still limited, despite hard efforts of scientists and clinicians during last few months. In this review article, we have collected the latest data about characteristics, pathogenesis, clinical manifestations, and diagnostic methods of SARS-CoV-2. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lotfi, Melika","Rezaei, Nima"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492197","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26123","keywords":["2019-ncov","covid-19","clinical manifestations","sars-cov-2","virulence"],"topics":["Diagnosis"],"weight":1,"_version_":1668892169337831425,"score":9.490897,"similar":[{"pmid":32374000,"title":"An update on the status of COVID-19: a comprehensive review.","text":["An update on the status of COVID-19: a comprehensive review.","The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).","Eur Rev Med Pharmacol Sci","Zhao, N","Zhou, Z-L","Wu, L","Zhang, X-D","Han, S-B","Bao, H-J","Shu, Y","Shu, X-G","32374000"],"abstract":["The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19)."],"journal":"Eur Rev Med Pharmacol Sci","authors":["Zhao, N","Zhou, Z-L","Wu, L","Zhang, X-D","Han, S-B","Bao, H-J","Shu, Y","Shu, X-G"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374000","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.26355/eurrev_202004_21046","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138496315686912,"score":148.04597},{"pmid":32462663,"title":"Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.","text":["Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.","Coronavirus disease 2019 (COVID-19) is a highly contagious disease with millions of people have been infected. However, there is limited data regarding clinical features, disease courses and outcomes of COVID-19 in patients with human immunodeficiency virus (HIV). Herein, we presented the demographic data, clinical characteristics and outcomes of nine confirmed COVID-19 patients with HIV infection admitted to our hospital located in south Bronx, New York City. Our study revealed very high mortality rate at 78%, which may contradict to the hypothesis that immunosuppression from HIV infection prevents against severe COVID-19. More research is needed to determine the impact of HIV on the clinical course of COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Suwanwongse, Kulachanya","Shabarek, Nehad","32462663"],"abstract":["Coronavirus disease 2019 (COVID-19) is a highly contagious disease with millions of people have been infected. However, there is limited data regarding clinical features, disease courses and outcomes of COVID-19 in patients with human immunodeficiency virus (HIV). Herein, we presented the demographic data, clinical characteristics and outcomes of nine confirmed COVID-19 patients with HIV infection admitted to our hospital located in south Bronx, New York City. Our study revealed very high mortality rate at 78%, which may contradict to the hypothesis that immunosuppression from HIV infection prevents against severe COVID-19. More research is needed to determine the impact of HIV on the clinical course of COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Suwanwongse, Kulachanya","Shabarek, Nehad"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462663","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26077","keywords":["covid-19","haart","hiv","sars-cov-2","mortality"],"locations":["Bronx","New York","Bronx","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668079521238089728,"score":132.90901},{"pmid":32275075,"title":"Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China.","text":["Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China.","Coronavirus disease 2019 (COVID-19), an infectious outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),(1) has now progressed to global pandemic.(2) Besides the compelling need to understand the novel biological pathways underlying the virulence and pathogenicity of SARS-CoV-2 in humans to enable the development of appropriate interventions and therapies,(3,4) the noticeable difference in mortality rates between Asian and European populations is one of the most significant issues demanding the attention of biologists, epidemiologists and clinicians around the world. This article is protected by copyright. All rights reserved.","J Med Virol","Lippi, Giuseppe","Mattiuzzi, Camilla","Sanchis-Gomar, Fabian","Henry, Brandon M","32275075"],"abstract":["Coronavirus disease 2019 (COVID-19), an infectious outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),(1) has now progressed to global pandemic.(2) Besides the compelling need to understand the novel biological pathways underlying the virulence and pathogenicity of SARS-CoV-2 in humans to enable the development of appropriate interventions and therapies,(3,4) the noticeable difference in mortality rates between Asian and European populations is one of the most significant issues demanding the attention of biologists, epidemiologists and clinicians around the world. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lippi, Giuseppe","Mattiuzzi, Camilla","Sanchis-Gomar, Fabian","Henry, Brandon M"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275075","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25860","keywords":["covid-19","comorbidity","coronavirus","epidemics","mortality","outbreak"],"locations":["Italy","China"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491649523712,"score":131.35785},{"pmid":32469437,"title":"A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.","text":["A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.","This literature review aims to provide a comprehensive current summary of the pathogenesis, clinical features, disease course, host immune responses, and current investigational antiviral and immunomodulatory pharmacotherapies, in order to facilitate the development of future therapies and measures for prevention and control. This article is protected by copyright. All rights reserved.","J Clin Pharmacol","Ren, Yunzhao R","Golding, Amit","Sorbello, Alfred","Ji, Ping","Chen, Jianmeng","Bhawana, Saluja","Witzmann, Kimberly","Arya, Vikram","Reynolds, Kellie S","Choi, Su-Young","Nikolov, Nikolay","Sahajwalla, Chandrahas","32469437"],"abstract":["This literature review aims to provide a comprehensive current summary of the pathogenesis, clinical features, disease course, host immune responses, and current investigational antiviral and immunomodulatory pharmacotherapies, in order to facilitate the development of future therapies and measures for prevention and control. This article is protected by copyright. All rights reserved."],"journal":"J Clin Pharmacol","authors":["Ren, Yunzhao R","Golding, Amit","Sorbello, Alfred","Ji, Ping","Chen, Jianmeng","Bhawana, Saluja","Witzmann, Kimberly","Arya, Vikram","Reynolds, Kellie S","Choi, Su-Young","Nikolov, Nikolay","Sahajwalla, Chandrahas"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469437","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jcph.1673","keywords":["covid-19","sars-cov-2","clinical characteristics","review","treatment"],"topics":["Treatment","Mechanism","Diagnosis","Prevention"],"weight":1,"_version_":1668167110036029440,"score":125.92767},{"pmid":32458546,"title":"Cutaneous manifestations of COVID-19: A review of the published literature.","text":["Cutaneous manifestations of COVID-19: A review of the published literature.","COVID-19 is a highly contagious respiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). COVID-19 outbreak, which caused thousands of deaths, has been declared a pandemic by the World Health Organization in March 2020. The infection has been reported to demonstrate different types of cutaneous manifestations including urticarial, maculopapular, papulovesicular, purpuric, livedoid, and thromboticischemic lesions. Given the high mortality rate of the infection, timely and accurate identification of relevant cutaneous manifestations may play a key role in the early diagnosis and management. In this study, we provide a review with a focus on the reported cutaneous manifestations of COVID-19. This article is protected by copyright. All rights reserved.","Dermatol Ther","Elmas, Omer Faruk","Demirbas, Abdullah","Ozyurt, Kemal","Atasoy, Mustafa","Tursen, Umit","32458546"],"abstract":["COVID-19 is a highly contagious respiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). COVID-19 outbreak, which caused thousands of deaths, has been declared a pandemic by the World Health Organization in March 2020. The infection has been reported to demonstrate different types of cutaneous manifestations including urticarial, maculopapular, papulovesicular, purpuric, livedoid, and thromboticischemic lesions. Given the high mortality rate of the infection, timely and accurate identification of relevant cutaneous manifestations may play a key role in the early diagnosis and management. In this study, we provide a review with a focus on the reported cutaneous manifestations of COVID-19. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Elmas, Omer Faruk","Demirbas, Abdullah","Ozyurt, Kemal","Atasoy, Mustafa","Tursen, Umit"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458546","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/dth.13696","keywords":["covid-19","coronavirus","cutaneous manifestations","skin"],"topics":["Diagnosis"],"weight":1,"_version_":1667967698869420032,"score":122.47392}]}